Objective. With the practice of warm cardiopulmonary bypass (CPB) at our in
stitution we have observed an apparent increase in heparin requirements. CP
B temperature predictability affects pharmacokinetics and differences in dr
ug metabolism can be expected. We hypothesized that heparin requirements wo
uld increase with increasing CPB temperature. Methods. Following Institutio
nal Review Board approval, we reviewed the charts of 354 patients undergoin
g primary coronary artery bypass graft surgery. We recorded patient demogra
phic data, CPB duration, heparin requirements, and temperature during CPB.
CPB was conducted between 24 degrees C and 37 degrees C. The Spearman's cor
relation coefficient, Pearson chi-square, and rank-sum tests were used for
data analysis. Results. Core temperature during CPB correlated with heparin
requirements (r = 0.13, p < 0.02). However, CPB duration was shorter in wa
rm patients than in cold patients (r = -0.455, p < 0.0001). Additional hepa
rin requirements adjusted for duration of CPB (units/minute) were also sign
ificantly greater in the warm group (p = 0.018). Conclusions. Maintenance o
f adequate heparin anticoagulation during CPB is clinically important. Warm
CPB patients required more heparin per minute than those undergoing cold C
PB, More frequent assessment of anticoagulation and administration of addit
ional heparin should be considered in patients undergoing warm CPB.